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The HPV1 E4 gene encodes a family of abundant nonstructural late proteins whose role in the virus life cycle is unknown.
Their localization to keratin filaments when expressed in cultured epithelial cells has suggested a possible involvement in
virus release by disturbing the integrity of the infected cell. Here we show that in naturally occurring HPV1-induced tumors,
the majority of the E4 protein (95%) exists as complexes which do not contain keratins. The identification of discrete
species of 34K, 58K, 70K, 88K, and 105K suggests that these are simple multimers of the 17K monomer, with very little of
the soluble E4 being present in complexes larger than 140K. The truncated 10/11K E4 species, which comprise the C-
terminal domain of E4, exist as trimers and dimers in vivo. Less than 5% of the E4 was present as complexes greater than
140K, and these were found to be insoluble. The 34K (dimer) and 58K (putative trimer) E4 complexes were components of
these larger structures. Neither E4 monomers nor E4 complexes could be shown to interact directly with keratins or with
keratin filaments although formation of the 105K E4 complex was abolished (and formation of the 58K species enhanced)
when keratins were present during E4 synthesis in vitro. We conclude that while E1òE4 may transiently associate with
keratins during synthesis, the two proteins do not stably associate via a direct interaction. The majority of the HPV1 E4 protein
in established tumors in vivo is neither filament associated nor contained in inclusion granules, but exists predominantly as
soluble cytoplasmic multimers. q 1996 Academic Press, Inc.
INTRODUCTION pressed during and after the onset of vegetative viral
DNA replication in the parabasal layers of infected skin.
The human papillomaviruses (HPVs) are small DNA The E4 proteins do not appear to be components of
tumor viruses which induce epithelial lesions at diverse assembled virions (Doorbar and Gallimore, 1987) and
histological sites and with varying degrees of severity are not essential for the formation of virus-like particles
(for review see Laimins, 1993; Mansur and Androphy, following expression of the L1 and L2 capsid proteins in
1993; Schneider, 1994). Over 70 different types of HPV vitro (Hagensee et al., 1993; Zhou et al., 1991). In Bovine
have so far been characterized (Villiers de, 1989) of which papillomavirus type 1, the E4 proteins have been found
a subset are associated with malignancies. The ‘‘high- not to be required for transformation or episomal replica-
risk’’ HPVs include types 16, 18, and 31, which have been tion of the viral genome (Neary et al., 1987), although the
implicated in the development of cervical cancers (Vil- expression of E4 does coincide with vegetative-like DNA
liers de, 1989; zur Hausen and Schneider, 1987), while amplification in growth-arrested cells (Jareborg and Bur-
‘‘low-risk’’ viruses, which include types 1, 2, 6, and 11, nett, 1991). The only assayable function for E4 is its inter-
induce primarily benign tumors. Despite differences in action with the epithelial cell intermediate filament (IF)
oncogenic potential and tissue tropism, all HPVs share network, which can occur following expression of the
a common genomic organization and are dependent on HPV 1, 16, and 31b E4 proteins in epithelial cells in vitro
the differentiation of the infected skin cell for the comple- (Doorbar et al., 1991; Pray and Laimins, 1995; Roberts et
tion of their life cycle. al., 1993), as well as in HPV 16-containing W12 cells after
The viral E4 proteins have been identified in benign grafting onto nude mice (Sterling et al., 1993). In naturally
lesions induced by HPV types 1, 2, 4, 6, 11, and 16 (Breit- occurring tumors and in some in vitro transfection experi-
burd et al., 1987; Brown et al., 1991, 1994; Crum et al., ments, however (Rogel-Gaillard et al., 1992, 1993), such
1990; Doorbar et al., 1986, 1989, 1992; Palefsky et al., an association is not readily apparent, and although the
1991; Tomita et al., 1991) and are expressed from a E4 proteins are predominantly cytoplasmic their distribu-
spliced mRNA (E1òE4), with the five N-terminal-most tion is not coincident with that of the cytoplasmic keratin
amino acids of E4 being derived from E1. Although origi- network (Breitburd et al., 1987; Brown et al., 1991; Crum
nally classified as early proteins their distribution in be- et al., 1990; Doorbar et al., 1986, 1989, 1992; Palefsky et
nign tumors reveals them to be late polypeptides ex- al., 1991; Tomita et al., 1991).
The E4 proteins have been studied most extensively
in cutaneous lesions caused by HPV1 (Breitburd et al.,1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 1223 336926. 1987; Doorbar et al., 1986, 1989; Grand et al., 1989; Rob-
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erts et al., 1994b; Rogel-Gaillard et al., 1992, 1993), where al., 1988), New England Biolabs, Beverly, MA) digested
with EcoRI. E1òE4 cDNAs were prepared using primerE4 is an abundant protein which first assembles into
cytoplasmic inclusion granules in cells of the lower spi- pairs CAG ATC TGA ATT CAT CGA AGG TCG TGC AGA
TAA TAA AGC TCC CCA AGG GCT G and CAG ATC TGAnous layers. During differentiation the primary E1òE4
gene products undergo N-terminal cleavage to produce ATT CTG TAC CTG AGA CAC TTA AGC TGA T for HPV1
and CGG ATC CGA ATT CAT CGA AGG TCG TGC GGAtruncated proteins which have lost the conserved N-ter-
minal leucine motif which has been implicated in keratin CGA TTC AGC ACT ACA CAA GAA G and CGG ATC CGA
ATT CCA ATT GGA TTC ACC TTG AAA T for HPV6. Theassociation (Doorbar et al., 1988; Roberts et al., 1994a).
Full-length E1òE4 is the predominant species only in HPV16 E1òE4 construct has been reported previously
(Doorbar et al., 1992). pcDNA3 16 E1òE4 and pcDNA3 1the lower spinous layers. Even here there is little E4/
cytokeratin colocalization as revealed by immunocyto- E1òE4 constructs were prepared by inserting the E1òE4
cDNAs between the EcoRI and XbaI sites of pcDNA3chemistry (Breitburd et al., 1987; Rogel-Gaillard et al.,
1993). The absence of certain keratin subtypes in these (Invitrogen BV, Holland). Primer pairs CGG GAT CCC
GAA TTC ACC ATG GCT GAT CCT GCA GCA GCA ACGcells has, however, lead to the suggestion that E4 may
be able to bind to keratin monomers so destabilizing and CGG GAT CCC GCT CTA GAG CTT ATG GGT GTA
GTG TTA CTA TTA CAG T were used for cloning thethem in order to inhibit the formation of differentiation
specific cytokeratin networks (Breitburd et al., 1987; HPV16 E1òE4 cDNA while GAA GAT CTT CGG AAT TCC
ACC ATG GCA GAT AAT AAA GCT CCC CA and GAADoorbar et al., 1991). It has been proposed that the E1òE4
protein alone may be sufficient for the formation of the GAT CTT CGC TCT AGA GCT TAC ACA GAC CAC GGG
TGG ATC CCA AG were used to clone the HPV1 E1òE4cytoplasmic inclusions characteristic of cutaneous papil-
lomaviruses (Rogel-Gaillard et al., 1993). gene. pcDNA3 K8 and pcDNA3 K18 recombinants were
prepared from keratin cDNA clones kindly provided byTo establish the state of the E4 proteins in vivo, and
to determine if E4 has direct affinity for cytokeratins, we Professor Birgit Lane (CRC Laboratories, University of
Dundee). Primer pairs used for K8 cloning were CCGhave studied E4 associations using proteins purified
from benign tumors induced by HPV1, as well as follow- GAA TTC ATG TCC ATC AGG GTG ACC CAG and GCG
TCT AGA TCA CTT GGG CAG GAC GTC AGA, whileing expression in vitro. Although the HPV1 E1òE4 pro-
teins showed some degree of keratin association follow- those for K18 were CGG GAA TTC ATG AGC TTC ACC
ACT CGC TCC and CCG TCT AGA TTA ATG CCT CAGing expression in culture, we were unable to demonstrate
any direct interaction with either purified keratin mono- AAC TTT GGT. Amplified fragments were cloned be-
tween the EcoRI and XbaI sites of pcDNA3. For the two-mers or filaments and found that in naturally occurring
tumors the majority of the E4 protein exists as soluble hybrid analysis cytokeratins 8 and 18 were cloned into
EcoRI/BamHI- or EcoRI-digested pGAD424 vector (Acti-multimers which do not contain keratins. Our results, as
well as those of others (Breitburd et al., 1987; Rogel- vation domain vector, Clontech, Palo Alto, CA) using the
N-terminal primers described above, and GCG GGA TCCGaillard et al., 1993), suggest that E4 has not evolved as
an efficient binder of the cytokeratin scaffold and that TCA CTT GGG CAG GAC GTC AGA and CCG GAA TTC
TTA ATG CCT CAG AAC TTT GGT as K8 and K18 C-where such interactions occur it may be mediated indi-
rectly. terminal primers, respectively. HPV16 and HPV1 E1òE4
sequences were cloned into the DNA binding domain
vector pGBT9 (Clontech) using the same primers as wereMATERIALS AND METHODS
used to construct the pcDNA3 recombinants, except that
Construction of plasmids and rescue of vaccinia virus
cloning was carried out between the EcoRI and BamHI
recombinants
sites for HPV16 E1òE4 and into the EcoRI site for the
E1òE4 cDNA of HPV1.The E1òE4 genes of HPV1 and HPV6 were amplified
from cloned HPV1 (Doorbar et al., 1989) or HPV6 DNA
(Schwarz et al., 1983) (generously provided by Dr. H. Cell culture and analysis of clinical biopsies
zur Hausen, DKFZ, Heidelberg, Germany) by polymerase
chain reaction using previously described primers HaCat and CV-1 cells were grown as previously de-
scribed, prior to infection with recombinant vaccinia(Doorbar et al., 1992) before being cloned into the BamHI-
digested vaccinia transfer vector pRK19 (Browne et al., virus (Doorbar et al., 1991). Clinical biopsies of cuta-
neous warts and verrucas were obtained from various1988). Recombinant vaccinia viruses expressing either
HPV6 or HPV1 E1òE4 proteins were recovered as pre- sources including the London Foot Hospital, Salford
School of Podiatry, and the Plymouth School of Podia-viously described. The HPV16 E1òE4- and L1-expressing
recombinants have been characterized previously try. Samples were snap frozen in liquid nitrogen follow-
ing receipt and were typed as HPV1 using the HPV1 E4-(Browne et al., 1988; Doorbar et al., 1991). The GST 6
E1òE4 and GST 1 E1òE4 constructs were prepared using specific monoclonal antibodies (MAbs) 4.37 and 9.95
(Doorbar et al., 1988).pGEX1 (Smith and Johnson, 1988) or pMal-C ((Maina et
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Immunological techniques performed as described previously (Milner et al., 1991)
except that the column buffer was 0.14 M NaCl, 0.5%
Indirect immunofluorescence and Western blotting NP-40, 10 mM Tris–Cl, pH 8.0. Fractions (0.5 ml) were
were carried out as described previously (Doorbar et al., collected and mixed with an equal volume of 5 M NaOH
1989, 1991). Cytokeratin MAbs Cam5.2 (anti-K8) and and left at 377 for 30 min to hydrolyze aminoacyl tRNAs.
LE65 (anti K18) were used for Western blotting, and LP34 Proteins were subsequently precipitated by the addition
(anti-K5, 6, 18) was used for immunofluorescence (re- of 1 ml of ice-cold 25% TCA/2% leucine followed by incu-
viewed in Lane and Alexander, 1990); kindly provided by bation on ice for 30 min. Precipitates were collected by
Irene Leigh, London Hospital, UK). Skin keratins were filtration onto GF/A filters prior to addition of 3 ml of
detected using either anti-keratin polyclonal antibody scintillation and counting. For keratin interaction assays,
raised in rabbits or AE1/AE3 MAb mixture (Boehringer purified keratin 8 or keratin 18 (1 mg each, Cymbus Bio-
Mannheim, Germany). Anti-ubiquitin was obtained from science, Southampton, UK) or BSA (Sigma, St. Louis, MO)
the same source. Anti-filaggrin was obtained from Bio- was added to the reaction mixture either prior to synthe-
genesis Ltd. (Bournemouth, UK). sis or after synthesis had occurred. When purified pro-
teins were added after E1òE4 synthesis the reaction mix-Density gradient centrifugation and column
ture was incubated for a further 30 min prior to analysischromatography
by column chromatography. Cotranslations were per-
formed essentially as described in Milner et al. (1991)Sucrose gradients were prepared by gently layering
sucrose solution (from 10 to 70% sucrose in PBS) into except that mRNA from more than one plasmid was
added to the translation reaction. E1òE4 proteins werea 14-ml ultracentrifuge tube starting with 70% sucrose.
Additional layers were added as 450-ml aliquots differing labeled with [3H]leucine whereas [35S]methionine was
used for keratin labeling. Cotranslation of E1òE4 andby 5% in their concentration. HPV1-induced warts were
finely chopped with a scalpel and ground in a mortar keratins together was achieved using both labeled amino
acids.and pestle in either PBS (135 mM NaCl, 2.5 mM KCl, 10
mM Na2HPO4 , 1.8 mM KH2PO4 , pH 7.2) or 150 mM NaCl,
Keratin purification, in vitro assembly, and iodination50 mM Tris–Cl, pH 8.0. After centrifugation to remove
insoluble debris (10,000 rpm, eppendorf centrifuge, 5
Keratins were purified from human skin biopsies (ob-
min) the soluble fraction (0.5 ml) was gently layered onto
tained at autopsy) and from cells in tissue culture (CV-1
the top of the gradient and spun at 30,000 rpm (207,
and HaCat) essentially as described in Achtstaetter et
Beckman SW40 rotor) for 18 hr. Samples (0.5 ml) were
al. (1986). Filaggrin purification and in vitro filament as-
collected by puncturing the bottom of the tube and were
sembly were done as described by Mack et al. (1993). For
analyzed by SDS gel electrophoresis. Gradient calibra-
filament assembly assays purified keratins were used at
tion was carried out in duplicate tubes using b-galactosi-
a concentration of 0.2 mg/ml and purified E4 proteins
dase (50 units), catalase (50 units), alkaline phosphatase
were added at an approximate 1:1 molar ratio. Assembly
(25 units), and lysozyme (500 mg). Enzyme markers were
assays and coimmunoprecipitation assays were carried
detected using the assay procedures suggested by the
out with human proteins (keratin and filaggrin). For coim-
manufacturers (Sigma, St. Louis, MO). Lysozyme was de-
munoprecipitation assays purified E4 proteins and skin
tected by SDS gel electrophoresis. The CsCl gradients
keratins were iodinated to a specific activity of between
were performed as for sucrose gradients except that
100 and 400 mCi/mmol using iodo-beads according to the
steps ranged from 1 to 1.8 g/ml CsCl and the gradients
manufacturer’s guidelines (Pierce, Rockford, IL). Proteins
were centrifuged overnight at 40,000 rpm (207, Beckman
were mixed at keratin:E4 molar ratios of between 5:1 and
SW40 rotor). Fraction densities were measured on a re-
1:1 in PBS (100 mg/ml final concentration) containing 2%
fractometer. The insoluble proteins obtained after centrif-
BSA and 0.5% NP-40 and were incubated at 377 for 30
ugation (above) were layered onto the top of the gradient
min to allow binding. After this time complexes were
and fractions were removed after centrifugation by care-
immunoprecipitated using MAb 4.37, 9.95, or polyclonal
ful pipetting. Fractions were dialyzed against 50 mM Tris,
anti-keratin antiserum (Harlow and Lane, 1988). For these
pH 8.0, prior to SDS gel electrophoresis. Affinity chroma-
experiments the purified keratins were solubilized in 8
tography was carried out using monoclonal antibody
M urea prior to being added (at 1 in 50 dilution) to the
4.37- and 9.95-coated protein G–Sepharose. Beads were
interaction mix.
prepared as described by Harlow and Lane (1988) with
bound antibody being coupled using dimethylpimelimi- Chemical cross-linking, two-hybrid analysis, and pull-
date. Following binding of E4 complexes proteins were down experiments
eluted using 100 mM trietylamine and fractions were
neutralized in 1 M Tris, pH 8.0, prior to analysis by SDS E4 proteins were extracted from HPV1-induced tumors
using nondenaturing buffers (PBS) as described abovegel electrophoresis. FPLC chromatography of transcrip-
tion/translation products on a superose 6 column was before being incubated (25 mg protein in 100 ml reaction
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mix) in the presence of 12.5 mM dimethyl 3,3* dithiobisp- Five additional proteins of molecular weight 78K, 57K,
55K, 39K, and 37K could also be detected (by Coomassieropionimidate (DTBP, Pierce, Rockford, IL) for 30 min at
room temperature. Cross-linking was also carried out blue staining), which did not react with either E4 or kera-
tin-specific antibodies (Fig. 1a). The 57 and 78K speciesusing dithiobis(succinimidylpropionate) (DSP, Pierce,
USA) at a concentration of 1.25 mM. Reactions were could be separated from the majority of the E4 by centrif-
ugation at 45,000 rpm (1 hr, Beckman Ultracentrifuge)stopped by adding 20 ml of 50 mM N-ethylmaleimide.
Cross-linked samples were run in the first dimension and were identified by Western blotting as the L1 and
L2 capsid proteins (Fig. 1a). Affinity purification of E4on a 12.5% SDS–acrylamide stick gel before cross-links
were broken by incubation of the gel in loading buffer from the remaining supernatant (using either anti-E1òE4
MAb (4.37) or polyclonal antibodies) did not allow us tocontaining 50 mM b-mercaptoethanol. The treated stick
gel was then placed on top of a standard 12.5% SDS- reproducibly identify any cellular partners for E4 which
were detectable by gel electrophoresis and staining withacrylamide gel and electrophoresed in the second di-
mension. E4 proteins were identified by Western blotting. Coomassie blue. When the supernatant was stored prior
to analysis, however (47, 1 hr), the 37K protein, whichTwo-hybrid interactions were analyzed using the pGBT9
and pGAD424 E1òE4 and keratin constructs described was identified as the intermediate filament-associated
protein filaggrin, coeluted with E4 at detectable levelsearlier. Methodologies for assaying interactions were es-
sentially as described in the Clontech Matchmaker sys- (Fig. 1a). Although filaggrin could both associate with E4
in vitro and mediate the association of E4 with keratinstem (Clontech, Palo Alto, CA). GST and MBP fusion pro-
teins (for interaction assays) were expressed from the in filament assembly assays (see later, Fig. 2b), we have
not yet been able to demonstrate the significance of thepGEX (Pharmacia, Upsala, Sweden) and pMal (Bio-Rad,
CA) E1òE4 recombinants essentially according to proto- association in HPV1-induced lesions in vivo. Filaggrin
was not detectable by immunofluorescence (using anti-cols suggested by the suppliers of the parental plasmids.
Bacteria were grown at 307 to an OD550 of 0.4 before filaggrin polyclonal and monoclonal antibodies) in cells
in which the HPV1 E1òE4 proteins were present (as re-being induced for 2 hr and harvested as described pre-
viously (Keen et al., 1994). ported by others (Rogel-Gaillard et al., 1993)). It is not
expressed in cells in culture (where E4/keratin associa-
tion has been reported) and does not appear to be aRESULTS
component of the soluble E4 complexes described below
Association of E4 with keratins in HPV1-induced
(as determined by Western blotting). As filaggrin is a
tumors in vivo
highly basic protein, and E4 acidic, it is possible that the
association occurs during purification rather than in situ.When expressed in epithelial cells in vitro the HPV1
E1òE4 proteins have been shown either to associate Comparative analysis of the E1òE4 proteins expressed
in vaccinia–E4-infected epithelial cells in vitro was at-with the keratin intermediate filament network (Roberts
et al., 1994b) or to assemble into cytoplasmic inclusion tempted, but was confounded by the low level of E1òE4
expression in this system. Like that of HPV16, the vac-granules similar to those observed in vivo (Rogel-Gaillard
et al., 1993). Using a vaccinia virus recombinant to direct cinia-expressed HPV1 E1òE4 protein was only just de-
tectable by Western blotting (Using ECL, see Doorbar,expression in CV-1 and HaCat cells (see Materials and
Methods), we have similarly found the HPV1 E1òE4 pro- 1991) and could not be visualized by staining with Coo-
massie blue.tein to colocalize to filaments, but not to induce their
collapse, as has been shown previously for the E1òE4 Of the E4 protein in benign tumors, less than 5% was
found to be insoluble. While some of this may be associ-protein of HPV16 (Doorbar et al., 1991). The HPV1 E1òE4
proteins were also detectable in the cytosol (where they ated with the IF network (as found in cells in culture),
several lines of evidence indicate that a significant frac-were not filament associated), but in our experiments did
not assemble into cytoplasmic inclusion granules. tion arises from the sedimentation of the cytoplasmic
inclusion granules characteristic of HPV1-induced warts.The physiological significance of the E4/keratin asso-
ciation was assessed in naturally occurring HPV1-in- First, following isopycnic centrifugation through a CsCl
gradient (containing b-mercaptoethanol; see Materialsduced tumors, where E4 expression is abundant. Surpris-
ingly, considering the in vitro findings, over 95% of the and Methods; Fig. 1b), the insoluble E4 proteins had
a buoyant density distinct from that of the cytoplasmictotal E4 proteins present in such tumors (as determined
by densiometric scanning following gel electrophoresis) intermediate filaments. Second, cross-linking of neigh-
boring proteins in the insoluble extract (using DSP andcould be extracted using detergent-free buffers (PBS (pH
7.2) or 50 mM Tris–Cl (pH 8.0), Fig. 1a, see (Breitburd et DTBP, see Materials and Methods) followed by solubili-
zation in 9 M urea (15 mM b-mercaptoethanol, 50 mMal., 1987)). This soluble extract contained all the pre-
viously reported members of the E4 family (as deter- Tris–Cl, pH 8.0) and immunoprecipitation (with E4-spe-
cific MAbs and polyclonal E4 antiserum as describedmined by Western blotting) and included both the full-
length 17K and the truncated 16K E4 species (Fig. 1a). below) failed to reveal cytokeratins as major E4-binding
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FIG. 1. Analysis of E4 proteins from naturally occurring HPV1-induced tumors. (a) Total protein extracted from a HPV1-induced tumor (using 9 M
urea, 15 mM b-mercaptoethanol, 50 mM Tris–Cl, pH 8.0) is shown in track 2. Proteins extractable in nondenaturing buffer (150 mM NaCl, 50 mM
Tris–Cl, pH 8.0) are shown in track 3. Proteins remaining in the insoluble pellet (following nondenaturing extraction) are shown in track 1. Track 4
shows proteins pelleted from the soluble extract by high-speed centrifugation (40K rpm 1 hr, containing virus particles) and track 5 shows proteins
remaining in the supernatant after this time. Track 6 contains 5 mg of purified filaggrin. Proteins were separated by SDS gel electrophoresis and
staining with Coomassie blue. The positions of the keratins (K), filaggrin (F), and E4 are indicated, along with the L1 and L2 capsid proteins (track
4), the 55K soluble protein, and the 37/39K proteins (which include filaggrin). A Western blot of proteins present in tracks 3, 4, 5, and 6 using E4-
specific monoclonal 4.37 is shown in tracks 7, 8, 9, and 10. Tracks 11, 12, and 13 are Western blots of proteins present in tracks 4, 5, and 6 using
either the L1-specific MAb Camvir1 (track 11) or an antibody to filaggrin (clone 576, tracks 12 and 13). (b) Insoluble cellular proteins derived from
a HPV1-induced wart were layered onto the top of a wide-range CsCl gradient containing 15 mM b-mercaptoethanol. After centrifugation, 18 1-ml
fractions were collected, dialyzed, and analyzed by gel electrophoresis and Western blotting using either cytokeratin polyclonal antibody (top panel)
or anti-E4 MAb 4.37 (second panel). The density of individual fractions is indicated, and the bottom panel shows, for comparison, the migration
profile of the soluble E4 fraction. Neither the insoluble nor the soluble E4 was found to band with the bulk of the cytokeratins. Molecular weight
markers are as described in (a).
partners. Finally, during alkaline–urea gel electrophore- phorylated in cells of the spinous layer where inclusion
granules are most prominent.sis, the insoluble E4 proteins migrated more slowly than
did soluble E4, suggesting a lesser degree of phosphory- Although the low levels of E4 present in many HPV-
induced lesions (e.g., those caused by HPV6 or 16) pre-lation (see later). E4 proteins are progressively phosphor-
ylated during terminal differentiation, being least phos- vent comparative analysis, immunostaining of naturally
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FIG. 2. Inability of the HPV1 E4 proteins to associate directly with keratins in vitro. (a) Purified keratins and E4 proteins labeled with 125I are
shown in tracks K and E4, respectively. Tracks 1–4 show immunoprecipitates using E4-specific MAbs following incubation of E4 with keratins at
molar ratios of 1:5 (track 1), 1:3 (track 2), 1:2 (track 3), and 1:1 (track 4). Track 5 shows precipitation of keratins (using anti-keratin polyclonal) from
the 1:5 mixture. Tracks 7–10 show the same experiment as in tracks 1–4 except that immunoprecipitates were carried out using the anti-keratin
polyclonal antibody. Track 6 shows precipitation of E4 proteins from the 1:5 mixture using MAb 4.37. No proteins were specifically immunoprecipitated
using preimmune rabbit polyclonal antisera. (b) Track K shows purified skin keratins while track A shows the E4/keratin assembly mixture prior to
dialysis from 9 M urea. The distribution of E4 and keratins in the supernatant and pellet following filament assembly and centrifugation (see
Materials and Methods) is shown in the neighboring tracks (S/N and P, left of markers). The majority of the keratins are found in the pellet while
E4 remains primarily in the supernatant. Molecular weight markers are shown in track M (43K, 29K, 18.4K, 14.3K, 6.2K, and 3K). Only when filaggrin
was present in the E4 preparation did the E4 protein coprecipitate with assembled filaments (tracks S/N and P, right of markers).
occurring tumors (by immunocytochemistry using E4- precipitated using either a specific polyclonal antibody
specific antisera) has not previously revealed an exten- to cytokeratins (prepared in this lab), MAbs to E4 (4.37
sive association of E4 with filaments. We conclude that or 9.95 MAbs (Doorbar et al., 1992)), or a control antibody
although the E4 proteins can associate with the cytokera- which had specificity for neither protein. Although we
tin network when expressed in epithelial cell in vitro, in were able to specifically immunoprecipitate both proteins
established lesions in vivo, only a small fraction of the (control antibodies did not precipitate either), the E4 and
E4 protein is in this state. keratins did not coprecipitate, suggesting that they do
not form a stable association by direct binding (Fig. 2a).
E1òE4 association with cytokeratins in vitro is Using a similar approach we have been unable to show
probably through an indirect interaction E4 association with keratin filaments following assembly
of purified monomers (Fig. 2b). Similar results were ob-Several differentiation-regulated proteins including
tained when E4 proteins were present in the monomerkeratin 1, keratin 10, filaggrin, and loricrin are absent (or
mix prior to filament assembly (see Materials and Meth-present at reduced levels) from cells in vivo which ex-
ods). The purified E4 proteins did not form a stable com-press E4. To reconcile this with the in vitro findings (as
plex with purified keratins.described above), it has been suggested that by binding
To rule out the possibility that E4’s ability to associatecytokeratins, E1òE4 may reduce their half-life and pre-
with keratins may have been lost during purification, thevent their assembly into normal keratin networks. Keratin
HPV1 E1òE4 coding sequence was cloned into the eu-filaments have a half-life of 100 hr, while monomers
karyotic expression vector pcDNA3 (downstream of thehave a half-life of 3 hr.
T7 promoter; Invitrogen BV, Holland). Following in vitroThe ability of the HPV1 E1òE4 protein to directly bind
transcription/translation (in a rabbit reticulocyte lysate,keratin filaments and keratin monomers was examined
[3H]leucine label) a 17K protein was produced (Fig. 3a)using proteins purified from normal human skin and
which could be specifically immunoprecipitated usingHPV1-induced warts (Fig. 2a). The purified cytokeratin
anti-HPV1 E4 monoclonals (4.37/9.95; data not shown).preparation contained keratins 1, 10, 5, and 14 (i.e., those
Comparable constructs containing the keratin 8 and 18characteristic of cutaneous skin (shown by Western blot-
genes and the E1òE4 ORF of HPV16 were also preparedting)), while both 16 and 17K E4 proteins were present
and similarly validated (Fig. 3a). No labeled productsin the E4 preparation (Fig. 2a). The minor E4 species (32/
were produced when in vitro synthesis was performed34K, 21/23K, and 10/11K) and the differentially phosphor-
using the parental vector with no insert (Fig. 3a). In natu-ylated variants of E4 were detected by Western blotting.
rally occurring lesions the HPV1 E1òE4 proteins are ex-After labeling to a specific activity of 100–400 Ci/mmol
pressed in cells containing K1 and K10, while that of(Fig. 2a), the E4 proteins were incubated with purified
HPV16 is produced in cells in which K4 and 13 are theskin keratins, in the presence of 5 mg/ml BSA (in PBS),
predominant types. Although our initial studies were withat keratin:E4 ratios ranging from 1:5 to 1:1 (final E4 con-
HPV1 E1òE4, K1, and K10 (described above), the fact thatcentration of approximately 1 mg/ml, see Materials and
Methods). After 1 hr, protein complexes were immuno- both E1òE4 proteins associated with filaments in simple
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epithelial cells, where K8 and 18 are predominant, has
lead us to perform further validation using this pair. Fur-
thermore, the HPV16 E1òE4 protein has been shown to
disrupt simple keratin networks (primarily K8/K18) more
rapidly than it does networks composed of skin keratins
(K5/K14) when expressed in cells in vitro. Cotranslation
and posttranslational mixing experiments (E1òE4 / K8,
K18, or both) followed by immunoprecipitation (using
specific antibodies) did not, however, reveal E1òE4 to
associate directly with keratin 8, 18, or 8/18 filaments
(discussed later). Neither did E1òE4 of either HPV type
interact with highly purified K8 or K18 when transcription/
translation was carried out in their presence. Under the
same conditions, K8 was found to interact with K18 to
form tetramers and filaments (Fig. 3b, see below), and
the E1òE4 protein of HPV1 was able to assemble, in the
absence of keratins, into high-molecular-weight struc-
tures of 105 and 385K (as discussed later, Fig. 3b).
The conclusion from these studies, that E1òE4 does
not associate with keratin filaments through a direct in-
teraction, was further supported by two-hybrid selection.
The HPV1 E1òE4 coding sequence was cloned as a GAL
4 DNA binding domain fusions into the yeast expression
plasmid pGBT9 (Clontech Laboratories Inc., USA). Kera-
tin 8 and 18 coding sequences were inserted into the
GAL 4 activation domain plasmid pGAD424 (Clontech).
Expression of E4 and keratin fusions was confirmed by
Western blotting using specific monoclonal antibodies
(Cam5.2, LE65, TVG 402, and 4.37; see Materials and
Methods), and the E1òE4/Gal4–DNA binding domain fu-
sion protein was shown not to activate the lacZ reporter
gene on its own following transformation of yeast SFY526
or HF7C cells (indicating that the E1òE4 proteins have
no inherent transactivation activity). No activation of the
lacZ gene could be detected when the K8 or K18 activa-
tion domain fusions were coexpressed with E1òE4, indi-
cating that the E1òE4 proteins are unable to bind to
keratin monomers in this system (even though HPV1 E4
can interact with itself ). Although it is possible that bind-
ing activity is lost when E1òE4 is expressed as a Gal4–
DNA binding domain fusion, these results are consistent
top panel. Molecular weight standards used for size determination
were thyroglobulin (669K), apoferritin (443K), alcohol dehydrogenase
(150K), albumin (66K), carbonic anhydrase (29K), cytochrome C (12.5K),
and aprotonin (6.5K). FPLC separation showed the HPV1 E1òE4 protein
migrating as two major complexes of 105K and 385K (middle panel).
The solid trace represents the average of five runs while the dashed
lines indicate the extremes observed between profiles. A minor peak
of 34K was just visible in some assays. The expected positions of theFIG. 3. Assembly of E4 and keratins into distinct complexes in vitro.
(a) Transcription/translation of keratin 8 (52K) and keratin 18 (45K) from E1òE4 monomer (17K) and the 21/23K E4 species are indicated by
arrows. The putative positions of E4 multimers of increasing size arerecombinant pcDNA constructs. Proteins were analyzed by SDS gel
electrophoresis. Molecular weight standards are shown to the left (6.5K, indicated beneath the profile. The 105K E4 species is in the range of
hexamer–octamer. Under identical conditions, keratins assembled into12.5K, 21.5K, and 30K) and right (14.3K, 30K, 46K, and 69K) of the gel.
The HPV1 E1òE4 protein migrated at 17K. No proteins were detectable dimers and tetramers when expressed singly (K8 (rrr), K18 (— r —),
bottom panel) and assembled into filaments (10,000K molecularwhen transcription/translation was performed with the parental plasmid
pcDNA3. (b) A calibration curve for the FPLC column is shown in the weight) when expressed together (K8 and 18 ( ), bottom panel).
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with the in vitro aggregation and coprecipitation data Both 21 and 23K complexes were components of larger
structures of molecular weight 29 and 31K, indicatingoutlined above. Overlay experiments also failed to reveal
a direct interaction between E4 and keratins (using la- that E4 can trimerize and that the C-terminal region of
the protein is important for this (Doorbar et al., 1988).beled E4 proteins and keratins) under conditions in
which K8 could be successfully shown to interact with Cytokeratins and keratin-derived fragments could not be
detected (by Western blotting) as components of any ofK18, and we have not observed any direct association
with keratins using a GST–E1òE4 pull-down approach. the E4 complexes contained within the soluble extract.
Although cross-linking analysis was performed on theOur exhaustive analysis of E4/keratin binding, while
comprising predominantly negative results, strongly sug- insoluble fraction, the E4 proteins were predominantly
high molecular weight, and discrete E4 spots were notgests that the stable association of E4 with intermediate
filaments does not occur through a simple direct interac- easy to visualize.
The discrete 45, 70, and 88K species which were de-tion. Our findings suggest that in vitro filament collapse
is most likely a consequence of an undetermined func- tectable in the soluble fraction (described above) could
be separated by rate-zonal centrifugation through su-tion of E4 which may in fact be mediated by a direct
association with other cellular components. crose gradients (Fig. 5a). Very little of the soluble E4
protein formed complexes larger than alkaline phospha-
tase (140K). The smaller 23, 21, 16, 11, and 10K speciesE4 assembles through self-association into discrete
(probable proteolytic cleavage products of the monomerhigh-molecular-weight structures in vivo
and dimer) remained toward the top of the gradient, indi-
cating their presence primarily in smaller particles.Although keratins do not appear to be major E4-associ-
ated proteins in naturally occurring HPV1-induced tu- These species are found in the more differentiated layers
of infected skin (Breitburd et al., 1987; Doorbar et al.,mors, several lines of evidence (including the assembly
of E4 into inclusion granules visible by immunofluores- 1986, 1988) in contrast to the primary species which are
prevalent in the lower spinous layers. The E4 proteinscence staining) suggest that E4 assembles into high-
molecular-weight structures in vivo. Gel electrophoresis present in size-separated complexes showed distinct mi-
gration patterns following alkaline–urea gel electropho-and Western blotting of E4 extracted from HPV1-induced
warts are characterized by the appearance not only of resis, indicating different levels of phosphorylation (Fig.
5b). None of the high-molecular-weight forms of E4 co-discrete E4 bands (of molecular weight 10, 11, 16, 17,
21, 23, 32, 34, and 45K, see refs (Breitburd et al., 1987; stained with antibodies to cytokeratins (polyclonal or
monoclonal) or to vimentin.Doorbar et al., 1986, 1988)) but by an E4 smear extending
to the top of the gel (Fig. 4a). Although many protein Although we have attempted similar biochemical frac-
tionation on the E4 proteins expressed in epithelial cellscomplexes must be disrupted by SDS solubilization, the
32/34K dimers are not completely disassembled, nor are in vitro (from recombinant vaccinia viruses expressing
the E1òE4 proteins of HPV1 and HPV16), the low levelsinteractions which give rise to the smear, suggesting that
at least in part, these E4 complexes are stabilized by of E1òE4 have so far precluded such analysis. Relative
to keratins, the vaccinia-expressed E1òE4 proteins arecovalent bonding. To identify discrete high-molecular-
weight forms of E4 (and to analyze their composition), only minor species and are present at levels close to
the limit of detectability by Western blotting (as reported18 HPV1-induced papillomas were examined. Five pre-
dominant E4 complexes of approximately 45K, 58K, 70K, previously (Doorbar et al., 1991)).
88K, and 105K were apparent following SDS gel electro-
phoresis (in 5 of the extracts) along with several less Influence of keratins on the assembly of E4 into high-
obvious species of 208K, 223K, 245K, and 263K (Fig. 4a). molecular-weight complexes in vitro
Chemical cross-linking using DSP or DTBP (Fig. 4a,
see Materials and Methods) confirmed the 32/34K spe- Assembly of E4 into complexes occurred spontane-
ously following expression in vitro by cell-free transcrip-cies to be a dimer of the 16/17K monomer. Although we
could not conclusively establish the composition of the tion/translation, giving rise to two complexes of molecu-
lar weight 105 and 385K. A smaller peak of 58K couldhigher molecular weight forms (due to the presence of
the high-molecular-weight E4 smear), E4 dimers were be detected when synthesis was performed in the pres-
ence of keratins (see below, Figs. 6b and 6c), and incomponents of the 45K and 58K species. The faint mono-
mer spot beneath the 58K complex (on the 2D gel, Fig. several runs a 34K species (putative E1òE4 dimer) was
apparent in the shoulder of the 105K peak (Fig. 3b). Ex-4a) suggests that the 58K species is an E4 trimer or
tetramer, while the 45K complex is probably a proteolyti- cept for the 385K species, the high-molecular-weight
E1òE4 complexes produced in vitro had counterpartscally cleaved version of this. Using a MAb whose epitope
is located in the C-terminal half of the protein (8.40 which could be detected in vivo (although their structure
may not be identical). As predicted from the above experi-(Doorbar et al., 1988)), the 21K band was confirmed as
a complex containing the 10 and 11K species (Fig. 4b). ments, cotranslation of E1òE4 along with keratins 8 and
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FIG. 4. Structure of HPV1 E4 complexes isolated from naturally occurring tumors. (a) E4 species of 45K, 58K, 70K, 88K, and 105K were apparent
in several HPV1-induced tumor extracts following SDS gel electrophoresis (12.5% acrylamide) and Western blotting to MAbs 4.37 and 9.95 (tracks
2 and 3, middle panel). Following electrophoresis through 7.5% acrylamide (and Western blotting), these high-molecular-weight E4 species were
easier to visualize (70K, 88K, and 105K; tracks 2 and 3, leftmost panel), as were species of even higher molecular weight (208K–263K). No bands
could be detected among proteins extracted from normal skin (track 1). Using the chemical cross-linking agent DTBP (see Materials and Methods)
followed by two-dimensional gel electrophoresis (in which cross-links are broken in the second dimension, rightmost panel), a number of E4 species
were found to migrate off the diagonal (small arrows) by Western blotting (using E4-specific MAbs 4.37 and 9.95). These represent components of
the large E4 complexes (large arrows). The 58K species is probably a trimer and the 34K form a dimer. Molecular weight markers (43K, 29K, 18.4K,
and 14.3K (12.5% and 2D gel); 205K, 116K, 97.4K, 66K, and 45K (7.5% gel)) are shown in track M. (b) Cross-linking and 2D gel electrophoresis of
the soluble E4 fraction (as above) followed by Western blotting using the E4-specific MAb 8.40 (which recognizes the 10/11K truncated E4 proteins).
The 10K, 11K, 21K, and 23K E4 species are marked on the diagonal (large arrows). The 10K, 11K, and 16K species (small arrows) were identified
as components of the 21K and 23K forms. The 21 and 23K complexes were in turn found to be components of larger E4 species of 29 and 31K,
suggesting that E4 can form trimers. The 32/34K proteins (small arrows) could also be detected in larger complexes.
18 (i.e., keratins with which E1òE4 associates following assembles into each complex, see Fig. 3b), the 58K spe-
cies was never detected in the absence of keratins, andexpression in epithelial cells in vitro) did not significantly
affect the FPLC profiles of either protein and did not lead the 105K complex was consistently lost when keratins
were added. We could not, however, conclusively estab-to abolition of filament formation when K8 and K18 were
translated together (cf. the in vitro filament assembly lish if loss of one species correlated with the appearance
of another. Traces shown in Fig. 6b represent the aver-assays described above). By contrast, the addition of
purified keratins (1 mg/reaction) prior to in vitro synthesis age of triplicate experiments. The addition of keratins to
preformed E1òE4 complexes never lead to loss of theof E1òE4 always resulted in failure of the 105K complex
to form and in the appearance of a 58K species (Figs. 105K complex (although the 58K complex could be de-
tected), nor did inclusion prior to E1òE4 synthesis of6b and 6c). While relative levels of the different E1òE4
complexes (385K, 105K, and 58K) varied between experi- proteins such as BSA (in place of purified keratins, Fig.
6c). In accordance with our earlier findings (describedments (reflecting variability in the extent to which E4
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tion, cf. expression from recombinant vaccinia viruses)
suggests that while we have been unable to show direct
and stable binding between E4 and keratins, a weak or
transient association may occur and may influence the
ability of E4 to assemble into complexes.
DISCUSSION
The E1òE4 proteins of HPV1 have previously been
shown to associate with keratin filaments following their
expression in certain epithelial cells in vitro (Doorbar et
al., 1991; Roberts et al., 1993, 1994a). Here we have
shown that in naturally occurring tumours (caused by
HPV1), the majority of the E4 protein (95%) is not fila-
ment-associated, but exists as soluble complexes which
range in size from 10K (truncated C-terminal region of
E4) to approximately 140K (size range of E4 hexamers
(102K) to octamers (136K)). These do not contain keratins
or abundant cellular proteins and appear to arise by self-
association via sequences within the C-terminal domain
of E4. The small fraction of E4 (less than 5%) which exists
in complexes larger than 140K is insoluble and probably
corresponds to the E4 inclusion granules which are a
characteristic feature of HPV1-induced lesions. The char-
FIG. 5. Size fractionation of E4 complexes from naturally occurring acteristic smear seen following SDS gel electrophoresis
tumors. (a) Soluble E4 proteins extracted from a HPV1-induced lesion most probably arises from a combination of E4 multimeri-
were fractionated by rate zonal centrifugation through a 5–30% sucrose zation and proteolysis by progressive N-terminal dele-
gradient. Twenty-four 0.5-ml fractions were collected and analyzed by
tion. Despite exhaustive efforts, we were unable to showSDS gel electrophoresis and Western blotting using anti-E4 MAb 4.37
that E1òE4 (17K monomer or complexes) can stably as-(top panel). Total unfractionated proteins are shown to the left (keratins
appear as unstained bands within the E4 smear) and molecular weight sociate with keratins (monomers or filaments) through a
markers are shown to the right (66K, 36K, 18.4K, and 14.3K). Gradient direct interaction, although formation of E4 complexes in
calibration was performed using b-galactosidase (540K), catalase vitro was affected when they were present in great ex-
(230K), alkaline phosphatase (140K), and lysozyme (14K) as markers
cess. The association seen in certain epithelial cells in(bottom panel). The soluble E4 proteins have a sedimentation coeffi-
vitro may thus arise from stabilization of a transient asso-cient smaller than that of b-galactosidase (540K). The majority of solu-
ble E4 has a sedimentation coefficient similar to, or smaller than, that ciation, perhaps by binding to an additional cellular factor
of alkaline phosphatase (140K). (b) The fractionated complexes (tracks or by additional posttranslational modifications. Our re-
3–5) extracted from a HPV1-induced wart (as above) were compared sults suggest that E4 has evolved not as an efficient
by alkaline– urea gel electrophoresis and Western blotting using MAb
keratin-binding protein, but suggest that E4 may have7.76 (which recognizes the 16 and 17K E4 proteins) in order to visualize
other roles in the virus life cycle compatible with its abun-the differently charged forms of E4. The insoluble E4 fraction (track 2)
contains only a subset of the total number of charged species which dant presence in vivo as soluble multimers in the cyto-
are present in the total extract (track 1). Track 3 contains the smaller plasm of infected cells.
E4 aggregates (as found in fraction 2 in a), while tracks 4 and 5 contain E4 function has remained elusive largely because of
the larger forms (as found in fractions 5 and 10, respectively, in a).
difficulties in studying viral gene expression in differenti-Samples were boiled in 9 M urea, 15 mM b-mercaptoethanol, 50 mM
ating epithelial cells in vitro. Proposed roles have in-Tris–Cl, pH 8.0, for 10 min prior to gel electrophoresis in order to
disrupt noncovalently bound complexes. cluded involvement in vegetative viral DNA replication
(perhaps by interfering with cellular factors which prevent
replication in the basal layer; Jareborg and Burnett, 1991;
above), exhaustive analysis did not reveal the E1òE4 Breitburd et al., 1987), control of virus maturation (or as-
proteins to form stable complexes with the added kera- sembly (Doorbar et al., 1986)), inhibition of terminal differ-
tins, and they could not be coimmunoprecipitated from entiation (to preserve the integrity of the infected skin
the major peaks using anti-keratin antisera. Although the cell, perhaps by interacting with death proteins (Rogel-
physiological significance is unclear, we conclude that Gaillard et al., 1992)), and mediation of virus release by
assembly of the HPV1 E1òE4 protein into complexes can disturbing the normal keratin intermediate filament cy-
be modulated by the presence of keratin monomers. The toskeleton through interaction (Doorbar et al., 1989,
ability to detect this only when keratins are present in 1991). Our inability to demonstrate a direct association
between E4 and keratins in vitro is unlikely to be due togreat excess over E4 (as in the cell-free synthesis reac-
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FIG. 6. Effect of keratins on E4 complex formation in vitro. (a) Cotranslation of keratins and HPV1 E1òE4. The top panel shows the FPLC profile
of keratins (labeled with [35S]methionine) when cotranslated with E1òE4 (K8 (rrr), K18 (— r —), or K8 and 18 together ( )). No significant
differences were apparent, compared to when keratins were synthesized in the absence of E1òE4 (see Fig. 3b). The bottom panel shows the
positions of the E1òE4 peaks (labeled with [3H]leucine). Profiles shown are typical of those observed in triplicate experiments. (b) Translation of
E1òE4 in the presence of existing keratins. The top panel shows the E1òE4 profile when synthesis was carried out in the presence of 20 mg/ml
of keratin 8 (rrr), keratin 18 (— r —), or keratin 8 and 18 together ( ). The 105K species was lost, and a 58K species was detectable (most
evident when purified K8 was present). The bottom panel shows comparable traces except that keratins (20 mg/ml) were added to the transcription/
translation mixture after the synthesis of the E1òE4 protein. No significant change in the formation of E1òE4 complexes could be observed except
for the appearance of the 58K peak when translation was carried out in the presence of K8. The profiles shown represent the average obtained
from triplicate experiments. (c) Detection of the 58K complex and loss of the 105K species were most apparent when keratin 8 was added prior to
translation of E1òE4 (K8 (— r —)). No alteration to the formation of E1òE4 complexes was apparent when BSA ( ) was added prior to the
translation of E1òE4.
inappropriate posttranslational modifications as the E4 fection of VX2R cells lead to the formation of E1òE4 inclu-
sion granules similar to those seen in vivo (Rogel-Gail-proteins were purified from warts (and contained the full-
length 17K E1òE4 species) and the keratins from human lard et al., 1992, 1993). Following expression in Cos-1
cells or SV40 transformed keratinocytes (from a recombi-skin. Furthermore, similar results were obtained from
two-hybrid analysis and from experiments using E1òE4 nant SV40 virus) the same E1òE4 protein was found to
associate with the cytokeratin matrix (Roberts et al.,prepared by cell-free synthesis. Although we found the
HPV1 E1òE4 protein to associate with intermediate fila- 1993), as reported here following expression in CV-1
cells (from a vaccinia–E1òE4 recombinant). While suchments following expression in CV-1 cells, such localiza-
tion has not been universally observed, but seems de- studies have been informative, they mimic only approxi-
mately the terminally differentiated keratinocyte in whichpendent on the cellular environment in which E4 is ex-
pressed. Transfection of SK-p cells with a pRSV-HPV1 E4 is expressed in vivo. We do not rule out that some
degree of association between E1òE4 and keratins mayE1òE4 vector, for instance, did not give rise to detectable
levels of E1òE4 (despite mRNA production), while trans- occur under some circumstances in vivo, but our results
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clearly demonstrate that in established HPV1-induced occurs in vitro. It remains to be established whether this
is the active form of E4 or whether the complexes and/ortumors (the most relevant situation), the majority of the E4
protein is not filament-associated. Although apparently granules constitute precursor structures similar to those
involved in the production of active filaggrin. Filaggrinindirect, the underlying mechanism for the keratin associ-
ation seen in vitro has been difficult to establish as only is synthesized as an inactive polyprotein of 350–1000K
molecular weight which is sequestered into cytoplasmiclow levels of E4 are produced from the vaccinia expres-
sion system. Preliminary analysis has, however, identi- inclusion bodies in cells of the epidermal granular layer
(Dale et al., 1993). Posttranslational processing (dephos-fied two cellular proteins of 70 and 80K which specifically
associate with E4 in cells in culture, and which may be phorylation and proteolysis) which occurs as the cell
moves into the cornified layer produces an active proteininvolved in mediating filament association in vitro. As
differentiation markers such as K1, K10, and loricrin are which subsequently aggregates keratin filaments (Dale
et al., 1993). The 17K HPV1 E1òE4 protein (although notdownregulated in HPV1-infected cells in vivo, it is an
intriguing possibility that E1òE4 may associate with kera- made as a polyprotein) is first detected in cells of the
lower spinous layer where a proportion of it assemblestins only at certain stages of tumor development. If this
is the case then we would predict the association to into inclusion granules. Posttranslational processing oc-
curs during differentiation by progressive proteolyticbe mediated indirectly or to depend on posttranslational
modifications which are not present on the soluble E4 cleavage (N-terminal sequences) and by phosphorylation
(Breitburd et al., 1987; Doorbar et al., 1988; Grand etproteins extracted from established tumors.
In addition to the soluble complexes (which have a al., 1989). N-terminal cleavage may have little effect on
complex formation, as the C-terminal domain alone (themaximum size of 140K), the HPV1 E4 protein also as-
sembles into much larger structures which are apparent 10 and 11K truncated forms of E4) was found to exist as
dimers and trimers. Phosphorylation, however, may haveas cytoplasmic inclusion granules. By immunohisto-
chemistry these do not stain with antibodies to keratins a significant effect. Our results suggest that E4 proteins
which comprise the very high-molecular-weight insoluble(or filaggrin), but stain with anti-E4 antibodies. The ab-
sence of soluble E4 complexes larger than 140K (com- E4 granules are less phosphorylated than those in the
smaller complexes and that the smaller particles containprising 6–8 E4 monomers) suggests either that species
larger than this exist as insoluble particles or that they the most highly modified protein. The E4 proteins have
previously been shown to become progressively phos-associate with insoluble cellular structures (or proteins).
Although we could separate the insoluble E4 proteins phorylated during terminal differentiation (Breitburd et al.,
1987).from the bulk of the intermediate filaments by density
gradient centrifugation, and could not show abundant While a role in keratin disruption may be one of E4’s
functions, the range of E4 species and their assemblyassociation with keratins using cross-linking agents, im-
munohistochemical analysis has previously revealed that into discrete complexes indicate a more subtle role. Its
accumulation in productively infected cells prior to cap-at least some of the E4 granules are associated with
the cytoskeleton at their periphery. Assembly of E4 into sid assembly strongly suggests importance in the late
stages of the virus life cycle. Understanding the signifi-complexes in vitro, in the presence or absence of inter-
mediate filaments, did not, however, lead to the formation cance of E4 complex formation, the effect of posttransla-
tional modifications, and the association of discrete spe-of very high-molecular-weight structures comparable
with the cytoplasmic inclusions seen in vivo even though cies with cellular components will provide important in-
formation in evaluating possible roles for the E4 protein.keratin monomers formed filaments of 10,000 molecu-
lar weight under these conditions. The inability of E1òE4
to assemble into larger structures may reflect the lack ACKNOWLEDGMENTS
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